Back To Search Results

External Cephalic Version

Editor: Caron J. Gray Updated: 12/13/2023 10:38:03 PM

Introduction

The global cesarean section rate has increased from approximately 23% to 34% in the past decade. Fetal malpresentation is now the third-most common indication for cesarean delivery, encompassing nearly 17% of cases. Almost one-fourth of all fetuses are in a breech presentation at 28 weeks gestational age; this number decreases to between 3% and 4% at term. In current clinical practice, most pregnancies with a breech fetus are delivered by cesarean section.

Individual and institutional efforts are increasing to reduce the overall cesarean delivery rate, particularly for nulliparous patients with term, singleton, and vertex gestations.[1][2] An alternative to cesarean delivery for fetal malpresentation at term is an external cephalic version (ECV), a procedure to correct fetal malpresentation. ECV may be indicated when the fetus is breech or in an oblique or transverse lie after 37 0/7 weeks gestation.[3] The overall success rate for ECV approaches 60%, is cost-effective, and can lead to decreased cesarean delivery rates.[4] ECV is of particular importance in resource-poor environments, where patients may have limited access to medical services during labor and delivery or where cesarean delivery is unavailable or unsafe.

Anatomy and Physiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Anatomy and Physiology

ECV can be attempted when managing breech presentations or fetuses with a transverse or oblique lie. Three types of breech presentation are established concerning fetal attitude: complete, frank, and incomplete, which is sometimes referred to as footling breech. In complete breech, the fetal pelvis engages with the maternal pelvic inlet, and the fetal hips and knees are flexed. In frank breech, the fetal pelvis engages with the maternal pelvic inlet, the fetal hips are flexed, the knees are extended, and the feet are near the head. In incomplete or footling breech, one (single footling) or both (double footling) feet are extended below the level of the fetal pelvis.

A fetus with a transverse lie is positioned with their long axis, defined as the spine, at a right angle to the long axis of the gravida. The fetal head may be to the right or left side of the maternal spine. The fetus may be facing up or down. The long axis of the fetus characterizes an oblique lie at any angle to the maternal long axis that is not 90°. An oblique fetus is usually positioned with their head in the right or left lower quadrants, although this is not universal.

Indications

ECV may be indicated in carefully selected patients. The fetus must be at or beyond 36 0/7 weeks of gestation with malpresentation, and there must be no absolute contraindications to vaginal delivery, such as placenta previa, vasa previa, or a history of classical cesarean delivery. Fetal status must be reassuring, and preprocedural nonstress testing is recommended. While ECV may be performed as early as 36 0/7 weeks gestation, many practitioners will delay ECV until 37 0/7 weeks gestation to ensure delivery of a term fetus.

ECV is more successful in multigravidas, those with a complete breech or transverse or oblique presentation, an unengaged presenting part, adequate amniotic fluid, and a posterior placenta. Nulliparous patients and those with an anterior, lateral, or cornual placenta have lower success rates. Patients with advanced cervical dilatation, obesity, oligohydramnios, or ruptured membranes also have lower success rates. Additionally, if the fetus weighs less than 2500 g, is at a low station with an engaged presenting part, is frank breech, or the spine is posterior, the success of ECV is decreased.[5] 

Evidence supports the use of parenteral tocolysis, most often with the beta-2-agonist medication terbutaline, to improve the success of ECV; most studies evaluating the various aspects of ECV aspects include using a tocolytic agent.[6][7][8][9] Data regarding the improved success of ECV incorporating regional anesthesia is inconsistent. 

Contraindications

Any contraindication to vaginal delivery would also be a contraindication to ECV. These contraindications include but are not limited to placenta previa, vasa previa, active genital herpes outbreak, or a history of classical cesarean delivery. A history of low transverse cesarean delivery is not an absolute contraindication to ECV.[10] The overall success rate of ECV in patients with a previous cesarean birth ranges from 50% to 84%; no cases of uterine rupture during ECV were reported in the four trials evaluating this outcome in patients with a prior cesarean delivery.[11][12][13][14]

Antepartum ECV is contraindicated in multiple gestations, although it can be utilized for twin gestations that would otherwise be suitable candidates for breech extraction.[15][16]

Patients with severe oligohydramnios, nonreassuring fetal monitoring, a hyperextended fetal head, significant fetal or uterine anomaly, fetal growth restriction, and maternal hypertension carry a low likelihood of successful ECV and a significantly increased risk of poor fetal outcomes; ECV in such situations requires careful consideration.

If a gravida who is otherwise a suitable candidate for ECV presents in early labor with fetal malpresentation, ECV may be a reasonable option if the presenting part is unengaged, the amniotic fluid index is within the normal range, and there are no contraindications to ECV or vaginal delivery. Data from the Nationwide Inpatient Sample from 1998 to 2011 noted a success rate of 65% for ECV performed in carefully selected patients during the admission for delivery.[17] ECV performed in this circumstance resulted in a significantly lower cesarean birth rate and hospital stay of greater than 7 days compared to patients with a persistent breech presentation at the time of delivery.[17]

Equipment

External cephalic versions should be attempted only in settings where cesarean delivery services are readily available. Therefore, the required equipment for ECV includes all such requirements for cesarean delivery, including anesthesia services. Access to tocolytic agents, bedside ultrasonography, and external fetal heart rate monitoring equipment is also required. Following ECV, fetal status must be assessed; nonstress testing is preferred. If nonstress testing is unavailable, Doppler indices of the umbilical artery, middle cerebral artery, and ductus venosus may be performed.[18]

Personnel

The personnel typically required to perform an ECV include:

  • Obstetrician
  • Labor and delivery nurse.

ECV may only be performed in a setting where cesarean delivery services are readily available. Personnel typically required for cesarean delivery include:

  • Obstetrician
  • Surgical first assistant
  • Anesthesia personnel
  • Surgical technician or operating room nurse
  • Circulating or operating room nurse
  • Pediatric personnel
  • Note: for cesarean delivery, labor and delivery nurses may serve as surgical technicians, circulating, or operating room roles.

Preparation

Before attempting ECV, informed consent must be obtained; this should include tocolysis and neuraxial analgesia if those procedures will be performed. Some clinicians will obtain consent from the patient for potential emergency cesarean delivery at this time, although this practice is not universal. Additionally, an ultrasound examination should be performed to verify fetal presentation, exclude fetal and uterine anomalies, locate the placental position, and evaluate the amniotic fluid index. Many clinicians will evaluate preprocedural fetal status with a nonstress test. 

The current evidence supports the administration of terbutaline 0.25mg subcutaneously 15 to 30 minutes before the ECV but does not support using calcium channel blockers or nitroglycerin for preprocedural tocolysis.[19] While multiple studies report the increased success of ECV in patients who are administered epidural or spinal neuraxial anesthesia, overall data is insufficient to warrant a universal recommendation; neuraxial anesthesia may improve success rates for ECV in situations where tocolysis alone was unsuccessful.[20]

Technique or Treatment

The gravida should be supine with a leftward tilt using a wedge support to relieve pressure on the great vessels. ECV is best performed using a 2-handed approach.

If the fetal presentation is breech, lift the breech out of the pelvis with one hand and apply downward pressure to the posterior fetal head to attempt a forward roll. If a forward roll is unsuccessful, a backward roll can be attempted. If the fetus is in either a transverse or oblique presentation, similar manipulation of the fetus is used to try to move the fetal head to the pelvis.[21]

Fetal well-being should be evaluated intermittently with Doppler or real-time ultrasonography during ECV. ECV should be abandoned if there is significant fetal bradycardia, patient discomfort, or if a version is not achieved easily. After a successful or unsuccessful ECV, external fetal heart rate monitoring should be performed for 30 to 60 minutes. If the gravida is Rh negative, anti-D immune globulin should be administered.

Immediate induction of labor to minimize reversion is not recommended. If the initial attempt at ECV is unsuccessful, additional attempts can be made during the same admission or at a later date.

Complications

Complications of ECV are rare and occur in only 1% to 2% of attempts. The most common complication associated with ECV is fetal heart rate abnormalities, particularly bradycardia, occurring at a rate of 4.7% to 20%; these abnormalities usually are transient and improve upon completion or abandonment of the procedure.

More severe complications of ECV occur at a rate of less than 1% and include premature rupture of membranes, cord prolapse, vaginal bleeding, placental abruption, fetomaternal hemorrhage, emergent cesarean delivery, and stillbirth. Many of these rare complications require emergent cesarean delivery; some clinicians choose to perform ECV in the operating room, although this is neither necessary nor universal.[22]  

ECV is associated with changes in Doppler indices that may reflect decreased placental perfusion. It appears these changes are short-lived and have no detrimental effects on the outcomes of uncomplicated pregnancies. A recent prospective study investigating the effects of ECV on fetal circulation in the antepartum period noted no differences in the Doppler evaluation of the middle cerebral artery or ductus venosus; all studied patients remained stable and were discharged home after the procedure.[18] 

Clinical Significance

Some data indicate that only 20% to 30% of eligible candidates are offered ECV.[23] Patients who undergo a successful ECV procedure have a lower cesarean delivery rate than patients who do not but are still at a higher risk of cesarean delivery than patients with cephalic fetuses who do not require ECV. ECV is cost-effective if the probability of a successful ECV exceeds 32%. Overall, ECV is successful in 58% of attempts, reduces the risk for CS by two-thirds, and enables 80% of these patients to deliver vaginally.[24]

Enhancing Healthcare Team Outcomes

ECV is not a benign procedure and is most successful when performed under the care of an interprofessional team. Labor and delivery nurses play an integral role in the success of ECV as they frequently assist in the procedure, prepare the patient for ECV, and implement external fetal monitoring before, during, and after the procedure. Additionally, the support of emergent operating room staff promotes the safe delivery of a healthy fetus should complications arise during the ECV procedure. Clear and concise anticipatory interprofessional communication improves safety and outcomes for the gravida and the fetus should complications occur.

References


[1]

Main EK. Leading Change on Labor and Delivery: Reducing Nulliparous Term Singleton Vertex (NTSV) Cesarean Rates. Joint Commission journal on quality and patient safety. 2017 Feb:43(2):51-52. doi: 10.1016/j.jcjq.2016.11.009. Epub 2016 Nov 15     [PubMed PMID: 28334562]

Level 2 (mid-level) evidence

[2]

American College of Obstetricians and Gynecologists (College), Society for Maternal-Fetal Medicine, Caughey AB, Cahill AG, Guise JM, Rouse DJ. Safe prevention of the primary cesarean delivery. American journal of obstetrics and gynecology. 2014 Mar:210(3):179-93. doi: 10.1016/j.ajog.2014.01.026. Epub     [PubMed PMID: 24565430]


[3]

Levin G, Rottenstreich A. Re: External cephalic version at term: a cohort study of 18 years' experience: External cephalic version at term: a need for modifiable predictor. BJOG : an international journal of obstetrics and gynaecology. 2019 Apr:126(5):675. doi: 10.1111/1471-0528.15537. Epub 2018 Dec 21     [PubMed PMID: 30575279]


[4]

Nalam RL, Chinnachamy P, Emmanuel P. External Cephalic Version: A Dying Art Worth Reviving. Journal of obstetrics and gynaecology of India. 2018 Dec:68(6):493-497. doi: 10.1007/s13224-018-1090-z. Epub 2018 Feb 8     [PubMed PMID: 30416278]


[5]

. What factors determine the success of an external cephalic version? BJOG : an international journal of obstetrics and gynaecology. 2019 Mar:126(4):501. doi: 10.1111/1471-0528.15586. Epub     [PubMed PMID: 30729658]


[6]

Fernandez CO, Bloom SL, Smulian JC, Ananth CV, Wendel GD Jr. A randomized placebo-controlled evaluation of terbutaline for external cephalic version. Obstetrics and gynecology. 1997 Nov:90(5):775-9     [PubMed PMID: 9351763]

Level 1 (high-level) evidence

[7]

Hakem E, Lindow SW, O'Connell MP, von Bünau G. External cephalic version - A 10-year review of practice. European journal of obstetrics, gynecology, and reproductive biology. 2021 Mar:258():414-417. doi: 10.1016/j.ejogrb.2021.01.044. Epub 2021 Jan 29     [PubMed PMID: 33550216]


[8]

Katz D, Riley K, Kim E, Beilin Y. Comparison of Nitroglycerin and Terbutaline for External Cephalic Version in Women Who Received Neuraxial Anesthesia: A Retrospective Analysis. Anesthesia and analgesia. 2020 Mar:130(3):e58-e62. doi: 10.1213/ANE.0000000000004155. Epub     [PubMed PMID: 30985380]

Level 2 (mid-level) evidence

[9]

Lomas S, Minton Z, Daniels JP. Systematic review of the effectiveness of remifentanil in term breech pregnancies undergoing external cephalic version. International journal of obstetric anesthesia. 2023 May:54():103649. doi: 10.1016/j.ijoa.2023.103649. Epub 2023 Mar 8     [PubMed PMID: 36989876]

Level 1 (high-level) evidence

[10]

Rosman AN, Guijt A, Vlemmix F, Rijnders M, Mol BW, Kok M. Contraindications for external cephalic version in breech position at term: a systematic review. Acta obstetricia et gynecologica Scandinavica. 2013 Feb:92(2):137-42. doi: 10.1111/aogs.12011. Epub 2012 Nov 1     [PubMed PMID: 22994660]

Level 1 (high-level) evidence

[11]

Sela HY, Fiegenberg T, Ben-Meir A, Elchalal U, Ezra Y. Safety and efficacy of external cephalic version for women with a previous cesarean delivery. European journal of obstetrics, gynecology, and reproductive biology. 2009 Feb:142(2):111-4. doi: 10.1016/j.ejogrb.2008.08.012. Epub 2008 Nov 18     [PubMed PMID: 19019528]

Level 2 (mid-level) evidence

[12]

Abenhaim HA, Varin J, Boucher M. External cephalic version among women with a previous cesarean delivery: report on 36 cases and review of the literature. Journal of perinatal medicine. 2009:37(2):156-60. doi: 10.1515/JPM.2009.006. Epub     [PubMed PMID: 19021458]

Level 3 (low-level) evidence

[13]

Burgos J, Iglesias M, Pijoan JI, Rodriguez L, Fernández-Llebrez L, Martínez-Astorquiza T. Probability of cesarean delivery after successful external cephalic version. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2015 Nov:131(2):192-5. doi: 10.1016/j.ijgo.2015.04.050. Epub 2015 Jul 29     [PubMed PMID: 26294171]


[14]

Keepanasseril A, Anand K, Soundara Raghavan S. Matched cohort study of external cephalic version in women with previous cesarean delivery. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2017 Jul:138(1):79-83. doi: 10.1002/ijgo.12169. Epub 2017 May 2     [PubMed PMID: 28380246]


[15]

Felder L, McCurdy R, Berghella V. External cephalic version of the non-cephalic presenting twin: a systematic review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2022 May:35(9):1712-1718. doi: 10.1080/14767058.2020.1768237. Epub 2020 May 20     [PubMed PMID: 32434414]

Level 1 (high-level) evidence

[16]

Bogner G, Wallner V, Fazelnia C, Strobl M, Volgger B, Fischer T, Jacobs VR. Delivery of the second twin: influence of presentation on neonatal outcome, a case controlled study. BMC pregnancy and childbirth. 2018 May 18:18(1):176. doi: 10.1186/s12884-018-1815-0. Epub 2018 May 18     [PubMed PMID: 29776396]

Level 2 (mid-level) evidence

[17]

Weiniger CF, Lyell DJ, Tsen LC, Butwick AJ, Shachar B, Callaghan WM, Creanga AA, Bateman BT. Maternal outcomes of term breech presentation delivery: impact of successful external cephalic version in a nationwide sample of delivery admissions in the United States. BMC pregnancy and childbirth. 2016 Jul 8:16(1):150. doi: 10.1186/s12884-016-0941-9. Epub 2016 Jul 8     [PubMed PMID: 27392035]


[18]

Engel O, Arnon S, Shechter Maor G, Schreiber H, Piura E, Markovitch O. The Effect of External Cephalic Version on Fetal Circulation: A Prospective Cohort Study. Children (Basel, Switzerland). 2023 Feb 10:10(2):. doi: 10.3390/children10020354. Epub 2023 Feb 10     [PubMed PMID: 36832483]


[19]

Mohamed Ismail NA, Ibrahim M, Mohd Naim N, Mahdy ZA, Jamil MA, Mohd Razi ZR. Nifedipine versus terbutaline for tocolysis in external cephalic version. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2008 Sep:102(3):263-6. doi: 10.1016/j.ijgo.2008.04.010. Epub 2008 Jun 12     [PubMed PMID: 18554601]

Level 1 (high-level) evidence

[20]

Magro-Malosso ER, Saccone G, Di Tommaso M, Mele M, Berghella V. Neuraxial analgesia to increase the success rate of external cephalic version: a systematic review and meta-analysis of randomized controlled trials. American journal of obstetrics and gynecology. 2016 Sep:215(3):276-86. doi: 10.1016/j.ajog.2016.04.036. Epub 2016 Apr 27     [PubMed PMID: 27131581]

Level 1 (high-level) evidence

[21]

Nagy J, Huvar I. [External cephalic version in breech presentation of fetus]. Ceska gynekologie. 2004 Nov:69(6):444-51     [PubMed PMID: 15633412]


[22]

Rodgers R. External cephalic version is associated with a low complication rate. BJOG : an international journal of obstetrics and gynaecology. 2019 Mar:126(4):500. doi: 10.1111/1471-0528.15514. Epub 2018 Dec 19     [PubMed PMID: 30461156]


[23]

Rauf B, Nisa M, Hassan L. External cephalic version for breech presentation at term. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2007 Sep:17(9):550-3     [PubMed PMID: 17903404]


[24]

Kim GJ. Reviving external cephalic version: a review of its efficacy, safety, and technical aspects. Obstetrics & gynecology science. 2019 Nov:62(6):371-381. doi: 10.5468/ogs.2019.62.6.371. Epub 2019 Oct 8     [PubMed PMID: 31777732]